Search results
Antibiotics in Infancy Tied to Higher Risk for Atopic Dermatitis
MedPage Today· 3 days agoUse of antibiotics early in life was linked to an increased risk of atopic dermatitis, likely driven...
AbbVie announces LEVEL UP results in atopic dermatitis study By Investing.com
Investing.com· 7 days agoThe study focused on adult and adolescent patients who had an inadequate response to systemic...
Tapinarof Cream for Adult, Pediatric Eczema Under FDA Review
Medscape· 2 days agoA decision on approval is expected in the fourth quarter of 2024.
Incyte Corp (INCY) Q1 2024 Earnings Call Transcript Highlights: Strategic Acquisitions and ...
GuruFocus.com via Yahoo Finance· 19 hours agoExplore key financial outcomes and strategic directions from Incyte Corp's first quarter of 2024, including significant acquisition and revenue details.
These Pictures Will Help You Identify the Most Common Skin Rashes
Prevention via Yahoo News· 5 days agoFrom eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos,...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters via AOL· 7 days agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a...
Incyte's (INCY) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 1 day agoThe year-over-year rise in sales was driven by patient demand and expansion in payer coverage as...
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...
Investing.com· 6 days agoAbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Analyst Report: Incyte Corporation
Morningstar Research via Yahoo Finance· 1 day agoIncyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta ...
Incyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 11 hours agoIncyte Corporation (NASDAQ:INCY) Q1 2024 Earnings Call Transcript April 30, 2024 Incyte Corporation...
